Profile
Michael Brines is the founder of Warren Pharmaceuticals, Inc. (founded in 2001) and Araim Pharmaceuticals, Inc. (founded in 2006), where he holds the titles of Chief Scientific Officer and Chief Science Officer, respectively.
He also worked at Yale University from 1989 to 1998, where he held the title of Co-Director in 1998.
Dr. Brines received his undergraduate degree from the University of Notre Dame, and his doctorate degrees from Yale University and The Rockefeller University (conferred in 1978).
Michael Brines active positions
| Companies | Position | Start |
|---|---|---|
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops tissue-protective technologies | Founder | 01/01/2001 |
Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops technology to address injuries and chronic diseases | Founder | 01/01/2006 |
Former positions of Michael Brines
| Companies | Position | End |
|---|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | 01/01/1998 |
Training of Michael Brines
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops tissue-protective technologies | Health Technology |
Araim Pharmaceuticals, Inc.
Araim Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops technology to address injuries and chronic diseases | Health Technology |
- Stock Market
- Insiders
- Michael Brines
















